Patent details

300855 Product Name: (2'R)-2'-desoxy-2'-fluor-2'-C-methyluridine-5'-trifosfaat

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
300855
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP2604620
Status:
Refused Art. 10 of the EC Regulations
Application number:
300855
Procedural language:
Dutch
First Applicant Residence Country:
United States of America (US)

Marketing Authorization

Marketing Authorization Number:
EU/1/13/894 (001-002)
Marketing Authorization Type:
EEA
Marketing Authorization Date:
17/01/2014
Marketing Authorization Country:
European Union (EU)

Dates

Filing date:
21/12/2016
First Marketing Authorization date:
17/01/2014
Grant date:
Activation date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
27/12/2016
SPC/SPC Extension Expiration Date:
Lapsed By Expiration Date:
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:
20/08/2019

Applicant/holder

From:
27/12/2016
 
 

 

Name:
Gilead Pharmasset LLC
Address:
c/o Gilead Sciences, Inc. 333 Lakeside Drive, FOSTER CITY, CA 94404, United States of America (US)

Agent

Name:
ir. H.A. Witmans c.s.
From:
27/12/2016
Address:
V.O. Postbus 87930, 2508 DH, Den Haag, Netherlands (NL)
To:

Publication

Bulletin

1

Bulletin Heading:
VRV
Journal edition number:
34/19
Publication date:
21/08/2019
Description:
Lapse or annulment

2

Bulletin Heading:
SPC
Journal edition number:
52/16
Publication date:
28/12/2016
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
Filing date Document type Document Description Number of pages File Type
20/08/2019 Outgoing Correspondence Decision refusal 2 PDF /5/0/4/8/1/0800118405/docs/300855_1_outgoingcorrespondence20190821020824434.pdf
29/11/2017 Examination Internal New 2 PDF /5/0/4/8/1/0800118405/docs/300855_6_examination20180215151746233.pdf
20/11/2017 Incoming Correspondence Paper Response applicant or agent 2 PDF /5/0/4/8/1/0800118405/docs/300855_4_incomingcorrespondencepaper20171122102529780.pdf
31/08/2017 Outgoing Correspondence Outgoing Letter 2 PDF /5/0/4/8/1/0800118405/docs/300855_5_outgoingcorrespondence20170904030541590.pdf
28/12/2016 Outgoing Correspondence Confirmation receipt request 1 PDF /5/0/4/8/1/0800118405/docs/300855_3_106851l174.pdf
22/12/2016 SPC Documents Marketing Authorization SPC 3 PDF /5/0/4/8/1/0800118405/docs/300855_0_supplprotectioncertificate20161227085404475.pdf
22/12/2016 Application Form First filed application form 3 PDF /5/0/4/8/1/0800118405/docs/300855_2_applicationform20161227085404289.pdf
22/12/2016 SPC Documents Summary of the characteristics of the product 42 PDF /5/0/4/8/1/0800118405/docs/300855_7_supplprotectioncertificate20161227085404563.pdf